Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Upgrade to version v3.2.0 with an operational status notice about potential delays and updated links; replaces the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:58:29.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Update indicates a version bump from v3.0.2 to v3.1.0. No other content changes are present.
    Difference
    0.0%
    Check dated 2025-09-29T03:13:54.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:58:30.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T17:02:29.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has added significant content related to various types of cancers and their treatments, including specific conditions and therapies, while removing some location-related information and certain medical terms.
    Difference
    4%
    Check dated 2025-08-31T12:09:14.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T04:37:57.000Z thumbnail image

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.